Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05251428 · ClinicalTrials.gov registry record · NA
Trigger Finger Trial
A NA study of Trigger Finger, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 6
- Study locations
NCT05251428: Completed NA study of Trigger Finger, sponsored by Emory University.
NCT05251428 is a NA study of Trigger Finger that has completed, run by Emory University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05251428, a NA study of Trigger Finger, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 6
- Study locations
Study Summary
Trigger finger is a common condition of the hand caused by the thickening of the A1 pulley or flexor tendon that alters the way in which the flexor tendon glides within the tendon sheath. The purpose of this study is to evaluate the efficacy of excision versus incision of the A1 pulley for the trigger finger. Researchers hypothesize that excision of the A1 pulley would result in lower trigger finger recurrence rates, better pain relief, reduced soreness \& stiffness as well as higher final Patient-Reported Outcomes Measurement (PROMs). This will be investigated via a randomized controlled study involving patients randomized in either of the aforementioned surgical treatment groups, which are both standards of care, at the Musculoskeletal Institute or at the Emory University Orthopaedic and Spine Hospital. Patients will then follow up in the clinic at 2 weeks, 6 weeks, 3 months, 6 months, and 1 year to assess their outcomes measures stated in the protocol document. All work related to this project will take place at the Emory Sports Medicine Complex, Emory Executive Park, Emory Musculoskeletal Institute, and the Emory University Orthopaedic and Spine Hospital. Patients will not be compensated for participating in this study. Patients who are undergoing trigger finger surgery will be identified by their Orthopaedic surgeon who is a member of the study team. The surgeon will briefly discuss participation with the patient and make clear study expectations.
Primary Outcome
Participants will be asked to complete questionnaires to evaluate their pain at each follow-up visit. The Visual Analog Scale will be the subjective measurement to evaluate changes in pain scores, with values ranging from 0 (no pain) to 10 (very severe pain). A higher score indicates worse pain.
Conditions Studied
Interventions
- PROCEDURE Excision of the A1 pulley
- PROCEDURE Incision of the A1 pulley in the standard fashion
Study Locations (6)
Georgia
- Emory Orthopedic and Spine Hospital - Atlanta
- 12 Executive Park Drive - Atlanta
- Emory Musculoskeletal Institute - Atlanta
- Emory Orthopaedics and Spine Center - Atlanta
- Emory at Dunwoody - Atlanta
- Emory Saint Joseph's Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-01-30 |
| Est. Completion | 2025-11-20 |
| Phase | NA |
What the finished NCT05251428 record still lists
NCT05251428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Trigger Finger appearing as the primary indexed condition, and to 2 interventions - of which Excision of the A1 pulley is the first listed.
NCT05251428 lists 6 locations in 1 state (Georgia).
Frequently Asked Questions
What is clinical trial NCT05251428 about?
NCT05251428 is a clinical study titled "Trigger Finger Trial". Trigger finger is a common condition of the hand caused by the thickening of the A1 pulley or flexor tendon that alters the way in which the flexor tendon glides within the tendon sheath. The purpose of this study is to evaluate the efficacy of excision versus incision of the A1 pulley for the trig...
What is the current status of trial NCT05251428?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-01-30. Estimated completion is 2025-11-20.
What conditions does trial NCT05251428 study?
This clinical trial studies the following conditions: Trigger Finger.
What interventions are being tested in trial NCT05251428?
The interventions under investigation include: Excision of the A1 pulley (PROCEDURE), Incision of the A1 pulley in the standard fashion (PROCEDURE).
Who is sponsoring clinical trial NCT05251428?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05251428 being conducted?
This trial has 6 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trigger Finger
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05251428's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI